China Botanic Pharmaceutical Inc. (CBP) reported third-quarter net income of $3.3 million, or $0.09 per share, compared to $2.5 million, or $0.0.07 per share in the same quarter a year ago.
Operating income was $3.8 million, up 26.8% from $3.0 million in the third quarter of fiscal 2011.
Net revenue increased 21.8% to $15.08 million from $12.38 million in the comparable quarter last year.
For fiscal year 2012, China Botanic reaffirmed its guidance of revenues of between $91.6 million and $93.1 million, representing an increase of 26% to 28% over fiscal year 2011 revenue of $72.7 million. The company expects net income to be in the range of $32.7 million to $33.2 million, representing an increase of between 26% and 28% over fiscal year 2011 net income of $25.9 million.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.